CN Patent

CN111437256A — 一种利鲁唑缓释口服混悬液

Assigned to Beijing Wanquan Dezhong Medical Biological Technology Co Ltd · Expires 2020-07-24 · 6y expired

What this patent protects

本发明属于药物制剂技术领域，公开一种利鲁唑缓释口服混悬液，同时解决药物平缓释放及老年儿童等吞咽困难人群给药顺应性问题。公开的的缓释混悬液由利鲁唑缓释微球分散于包含稀释剂、矫味剂、助悬剂、防腐剂、pH缓冲剂的溶液中制备而成，所述利鲁唑缓释微球由利利鲁唑溶于乙基纤维素水分散体经喷雾干燥制备而成。本发明的利鲁唑缓释口服混悬液与目前市场上的普通片剂、胶囊、口服混悬液相比，药物释放平缓，给药次数减少，质量稳定，口感良好，给药顺应性高，适用于老人和儿童等吞咽困难人群。

USPTO Abstract

本发明属于药物制剂技术领域，公开一种利鲁唑缓释口服混悬液，同时解决药物平缓释放及老年儿童等吞咽困难人群给药顺应性问题。公开的的缓释混悬液由利鲁唑缓释微球分散于包含稀释剂、矫味剂、助悬剂、防腐剂、pH缓冲剂的溶液中制备而成，所述利鲁唑缓释微球由利利鲁唑溶于乙基纤维素水分散体经喷雾干燥制备而成。本发明的利鲁唑缓释口服混悬液与目前市场上的普通片剂、胶囊、口服混悬液相比，药物释放平缓，给药次数减少，质量稳定，口感良好，给药顺应性高，适用于老人和儿童等吞咽困难人群。

Drugs covered by this patent

Patent Metadata

Patent number
CN111437256A
Jurisdiction
CN
Classification
—
Expires
2020-07-24
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Wanquan Dezhong Medical Biological Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.